Clene Inc. at Cantor Fitzgerald Global Healthcare Conference Transcript
Clene is a company that is, I think, a very interesting -- has a very interesting platform -- very novel platform. It is a company that is developing nanoparticles, if you will, for improving neurological disorder.
And it's a pleasure to introduce Mr. Rob Etherington, the Company's President and CEO. Rob is going to run through a presentation, and talk a little bit about what they're doing in the platform, and then hopefully talk about some very interesting data in ALS that we've seen recently updated, and speak to plans forward -- moving forward with that data. And so Rob, go ahead. Take it away, and I'll probably interrupt.
Please do, Charles. Thank you. It's a pleasure to be with you today. Thank you for joining us. So after some forward looking statements that you've seen before, I'll make a number of statements that we are under no obligation to update. I'll jump straight in.
So this is a presentation that I'm gonna really try to spend focus time on
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
